Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (191-200 of 1,279) with videos related to

Pageof 128
Sort By:
Medicina Clinica|February 27, 1988
[Gallbladder empyema caused by Salmonella enteritidis]J C López-Talavera, M Buti, R Esteban, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Hepatitis D epidemiology and access to diagnostic testing among healthcare providers in Africa: A multi-country surveyMaria Buti, C Wendy Spearman, Karin Siebelt, et al.
Journal of Hepatology|June 28, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
American Journal of Physical Anthropology|September 3, 2015
Allometry, merism, and tooth shape of the lower second deciduous molar and first permanent molarShara E Bailey, Stefano Benazzi, Laura Buti, et al.
Anti-Cancer Drugs|January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
Acta Bio-Medica : Atenei Parmensis|May 8, 2015
Retroperitoneal cystoadenocarcinoma: a case report with a literature reviewDaniele Zanoni, Angelica Sikokis, Melissa Bersanelli, et al.
Expert Review of Clinical Pharmacology|September 11, 2018
The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugsCarlos Roncero, Jose Luis Villegas, Maria Martínez-Rebollar, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Digestive Diseases and Sciences|April 12, 2000
Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis CM Buti, G Olive, C Stalgis, et al.
Pageof 128

Showing results (191-200 of 1,279) with videos related to

Sort By:
Pageof 128
Medicina Clinica|February 27, 1988
[Gallbladder empyema caused by Salmonella enteritidis]J C López-Talavera, M Buti, R Esteban, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Hepatitis D epidemiology and access to diagnostic testing among healthcare providers in Africa: A multi-country surveyMaria Buti, C Wendy Spearman, Karin Siebelt, et al.
Journal of Hepatology|June 28, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
American Journal of Physical Anthropology|September 3, 2015
Allometry, merism, and tooth shape of the lower second deciduous molar and first permanent molarShara E Bailey, Stefano Benazzi, Laura Buti, et al.
Anti-Cancer Drugs|January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
Acta Bio-Medica : Atenei Parmensis|May 8, 2015
Retroperitoneal cystoadenocarcinoma: a case report with a literature reviewDaniele Zanoni, Angelica Sikokis, Melissa Bersanelli, et al.
Expert Review of Clinical Pharmacology|September 11, 2018
The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugsCarlos Roncero, Jose Luis Villegas, Maria Martínez-Rebollar, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Digestive Diseases and Sciences|April 12, 2000
Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis CM Buti, G Olive, C Stalgis, et al.
Pageof 128